Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal Lactobacillus reuteri to prevent infantile colic
IRCT20131004014882N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2019
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of lactobacillus reuteri in infant colic, sponsored by Isfahan University of Medical Sciences. Started Aug 2019; status: completed.
02
Drugs
lactobacillus reuteri
03
Conditions
infant colic
Beyond the preview
Go deeper on IRCT20131004014882N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131004014882N7.